Bacterial Infections in Patients with Cancer: New Challenges, New Opportunities Pre-Activity Survey Question Title * 1. My current profession is: Physician Nurse Pharmacist Other (please specify) Question Title * 2. Which of the following would you consider to be risk factors for a multidrug-resistant (MDR) bacterial infection? (check all that apply)? High frequency of resistance in the hospital unit Current hospitalization for >3 days Hospital admission through the Emergency Department Prior hospitalization in the previous 3 months Prior antimicrobial use in the previous 3 months Residence in a nursing home Frequent travel Other (please specify) Question Title * 3. What do you consider to be the greatest challenge when managing MDR bacterial infections in cancer patients? Timely diagnosis Lack of effective agents Patient comorbidities Drug interactions Infection control Other (please specify) Question Title * 4. What barriers to the optimal management of MDR infections continue to be in place at your institution? Lack of qualified personnel/resources Non-adherence to evidence-based guidelines Non-compliance to infection control measures Lack of educational resources/opportunities Resistance to change Other (please specify) Question Title * 5. Please rank the following bacterial pathogens as you feel are the greatest threat to hospitalized patients with cancer (1=greatest threat, 5=least threat) 1 2 3 4 5 Staphylococcus aureus (including MRSA) 1 2 3 4 5 ESBL-producing Enterobacteriaceae 1 2 3 4 5 Carbapenem-resistant Enterobacteriaceae (CRE) 1 2 3 4 5 Pseudomonas aeruginosa 1 2 3 4 5 Clostridium difficile Question Title * 6. What do you consider to be the greatest challenge when managing C. difficile infections in patients with cancer? Timely diagnosis Patient comorbidities Infection recurrence Infection control Other (please specify) Question Title * 7. What do you feel you need to learn about the management of MDR infections? (Check all that apply) Evolving etiology of MDR infections Prevalence of antimicrobial resistance Patient risk factors for MDR infection Current evidence-based guidelines Selecting appropriate empiric therapy Adverse events associated with antimicrobials Duration of treatment Infection control strategies Other (please specify) Question Title * 8. Additional Comments and Questions Thank you for completing the survey. Done